Immatics N.V. SEC filings IMTX
Immatics N.V. has 243 filings in SEC EDGAR's recent list, going back to Apr 16, 2020. Its latest annual report, Form 20-F, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 26, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B2 | Prospectus | Aug 25, 2026 | — |
| S-8 | Employee stock plan registration | Jun 25, 2026 | — |
| 424B5 | Prospectus supplement | Dec 5, 2025 | — |
| 424B5 | Prospectus supplement | Dec 5, 2025 | — |
| S-8 | Employee stock plan registration | Jul 2, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 27, 2025 | — |
| 424B2 | Prospectus | Oct 11, 2024 | — |
| 424B2 | Prospectus | Oct 10, 2024 | — |
| F-3ASR | Filing | Oct 10, 2024 | — |
| S-8 | Employee stock plan registration | Jul 22, 2024 | — |
| 424B5 | Prospectus supplement | Jan 19, 2024 | — |
| 424B5 | Prospectus supplement | Jan 17, 2024 | — |
| 424B3 | Prospectus | Sep 13, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 25, 2023 | — |
| 424B5 | Prospectus supplement | Oct 11, 2022 | — |
| 424B5 | Prospectus supplement | Oct 11, 2022 | — |
| S-8 | Employee stock plan registration | Jun 24, 2022 | — |
| POS AM | Form pos am | Aug 2, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 2, 2021 | — |
| 424B3 | Prospectus | Jun 22, 2021 | — |
| 424B3 | Prospectus | May 26, 2021 | — |
| 424B3 | Prospectus | May 18, 2021 | — |
| 424B3 | Prospectus | May 11, 2021 | — |
| POS AM | Filing | Mar 30, 2021 | — |
| 424B3 | Prospectus | Mar 17, 2021 | — |
| 424B3 | Prospectus | Dec 2, 2020 | — |
| 424B3 | Prospectus | Oct 9, 2020 | — |
| S-8 | Employee stock plan registration | Oct 9, 2020 | — |
| F-1/A | Amendment no. 1 to form f-1 | Aug 11, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Jul 31, 2020 | — |
| 424B3 | Prospectus | Jun 10, 2020 | — |
| F-4/A | Amendment no. 4 to form f-4 | Jun 10, 2020 | — |
| F-4/A | Amendment no. 3 to form f-4 | Jun 8, 2020 | — |
| F-4/A | Amendment no. 2 to form f-4 | Jun 5, 2020 | — |
| F-4/A | Amendment no. 1 to form f-4 | May 22, 2020 | — |
| F-4 | Filing | Apr 16, 2020 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IMTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Tubingen, Germany
- SEC filer status
- Accelerated filer
- SEC CIK
- 1809196
- Former names
- Immatics B.V. (until Jul 8, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.